Proteolytic degradation of the extracellular matrix (ECM) is one intrinsic property of metastatic tumor cells to breach tissue barriers and to disseminate into different tissues. This process is initiated by the formation of invadopodia, which are actin-driven, finger-like membrane protrusions. Yet, little is known on how invadopodia are endowed with the functional machinery of proteolytic enzymes [1, 2] . The key protease MT1-MMP (membrane type 1-matrix metalloproteinase) confers proteolytic activity to invadopodia and thus invasion capacity of cancer cells [3] [4] [5] [6] . Here, we report that MT1-MMP-dependent matrix degradation at invadopodia is regulated by the v-SNARE TI-VAMP/VAMP7, hence providing the molecular inventory mediating focal degradative activity of cancer cells. As observed by TIRF microscopy, MT1-MMPmCherry and GFP-VAMP7 were simultaneously detected at proteolytic sites. Functional ablation of VAMP7 decreased the ability of breast cancer cells to degrade and invade in a MT1-MMP-dependent fashion. Moreover, the number of invadopodia was dramatically decreased in VAMP7-and MT1-MMP-depleted cells, indicative of a positive-feedback loop in which the protease as a cargo of VAMP7-targeted transport vesicles regulates maturation of invadopodia. Collectively, these data point to a specific role of VAMP7 in delivering MT1-MMP to sites of degradation, maintaining the functional machinery required for invasion.
Proteolytic degradation of the extracellular matrix (ECM) is one intrinsic property of metastatic tumor cells to breach tissue barriers and to disseminate into different tissues. This process is initiated by the formation of invadopodia, which are actin-driven, finger-like membrane protrusions. Yet, little is known on how invadopodia are endowed with the functional machinery of proteolytic enzymes [1, 2] . The key protease MT1-MMP (membrane type 1-matrix metalloproteinase) confers proteolytic activity to invadopodia and thus invasion capacity of cancer cells [3] [4] [5] [6] . Here, we report that MT1-MMP-dependent matrix degradation at invadopodia is regulated by the v-SNARE TI-VAMP/VAMP7, hence providing the molecular inventory mediating focal degradative activity of cancer cells. As observed by TIRF microscopy, MT1-MMPmCherry and GFP-VAMP7 were simultaneously detected at proteolytic sites. Functional ablation of VAMP7 decreased the ability of breast cancer cells to degrade and invade in a MT1-MMP-dependent fashion. Moreover, the number of invadopodia was dramatically decreased in VAMP7-and MT1-MMP-depleted cells, indicative of a positive-feedback loop in which the protease as a cargo of VAMP7-targeted transport vesicles regulates maturation of invadopodia. Collectively, these data point to a specific role of VAMP7 in delivering MT1-MMP to sites of degradation, maintaining the functional machinery required for invasion.
Results and Discussion

MT1-MMP Colocalizes with the v-SNARE VAMP7 at Focal Sites of Degradation
Among the matrix-proteinases, MT1-MMP has been widely shown to be required for matrix degradation and remodeling by invasive tumor cells [4, [6] [7] [8] [9] . However, the dynamic and coordinated targeting of the transmembrane enzyme MT1-MMP by cytoplasmic factors to sites of degradation has been subject of little investigation. It is well established that MT1-MMP is rapidly endocytosed from the plasma membrane and reaches early and late endocytic structures ( [10] , [11] , and our unpublished data). Endocytosis and recycling have been proposed as a mechanism for controlling MT1-MMP activity during matrix degradation [10] [11] [12] [13] [14] , and recently, a Rab8-dependent pathway was also suggested to contribute to MT1-MMP exocytosis during collagen degradation [15] .
We first set out to explore the subcellular localization of MT1-MMP, visualized as fluorescently tagged fusion protein (MT1-MMP-mCherry). MDA-MB-231 human breast cancer cells stably expressing MT1-MMP-mCherry (MDA-MT1ch cells, Sakurai-Yageta et al. [16] ) were counterstained for EEA1 (early endosomal antigen 1) and LAMP1 (lysosomalassociated membrane protein 1), respectively (see Figure S1 available online). The majority of MT1-MMP-mCherry colocalized with the late endosome (LE)/lysosomal compartment marker LAMP1 ( Figure S1B ), whereas only few MT1-MMPmCherry was found in early endosome (EE) compartments, as visualized by anti-EEA1 staining ( Figure S1A ).
It is so far unknown to what extent MT1-MMP trafficking from EE to LE/lysosomes might represent a degradative pathway for the protease [10] . Here, we rather wondered whether this accumulation of MT1-MMP in LE/lysosomal endocompartments could also reflect a storage pool that is involved in active translocation to the plasma membrane. This would require a specific fusion machinery regulating exocytosis of these endocompartments. SNARE (soluble NSF [N-ethylmaleimide-sensitive factor] attachment protein receptor) proteins constitute the basic machinery for membrane fusion, thereby acting in all membrane trafficking steps [17] [18] [19] . TI-VAMP/ VAMP7 (referred to as VAMP7 herein) was identified as a vesicular (v-) SNARE mainly present on the TGN (trans-golgi network) and LE/lysosomal structures [20, 21] and was shown to contribute to neurite outgrowth [22, 23] , GLUT4 release [24] , apical targeting in polarized epithelial cells [20, 25] , phagocytosis [26] , and cytokinesis [27] . Altogether, these results led to the conclusion that VAMP7 is the v-SNARE responsible for LE/lysosomal exocytosis (for review, see [28] ). VAMP7 staining in MDA-MT1ch cells ( Figure 1A ) revealed a high degree of colocalization with MT1-MMP, corroborating localization of MT1-MMP to LE/lysosomal structures and raising the possibility that VAMP7 could regulate the fusion of MT1-MMPcontaining endosomes with the plasma membrane. When analyzed by live-cell imaging, GFP-VAMP7 and MT1-MMPmCherry expressed in MDA-MB-231 cells also displayed a high degree of colocalization in large static vesicular structures in the juxtanuclear region of the cells as well as in smaller, highly dynamic vesicles ( Figures 1B and 1B 0 and Movie S1). When MDA-MT1ch cells were plated on fluorescently labeled crosslinked gelatin in an assay monitoring matrix degradation [4] , regular epifluorescence imaging revealed in rare cases a weak signal of the protease (MT1-MMP-mCherry, see Figure 2F ) at sites of degradation appearing as black holes in the fluorescent gelatin ( Figure 2C ). However, we were unable to detect GFP-VAMP7 at these sites ( Figure 2E ). In contrast, selective illumination of the ventral plasma membrane by TIRF microscopy showed a strong correlation between MT1-MMP-mCherry and sites of degradation (compare Figure 2B with Figure 2C ). Furthermore, we found GFP-VAMP7 colocalizing and accumulating with the protease at the ventral plasma membrane at focal sites of proteolysis (Figures 2A-2D , 2G, and 2H). This suggests that although the proteolytic activity resulting in loss of fluorescence of gelatin is mediated by the protease MT1-MMP, the v-SNARE VAMP7 targets its cargo to focal sites of degradation. It should be noted that GFP-VAMP7 was neither always detected at (see also Figure 3D ) nor restricted to degradative sites ( Figure 2D , arrowhead). Because delivery of cargo is a dynamic process involving recycling of the fusion machinery, disappearance of the v-SNARE upon fusion by rapid recycling is likely. Moreover, we cannot exclude that VAMP7 may also transport other cargo(es) different from MT1-MMP. Nevertheless, the strong colocalization of GFP-VAMP7 with MT1-MMP-mCherry at sites of degradation suggests that VAMP7 may be a critical v-SNARE delivering MT1-MMP to its site of action.
Time-lapse TIRF microscopy of MDA-MB-231 cells expressing MT1-MMP-mCherry and GFP-VAMP7 revealed a dynamic recruitment of GFP-VAMP7 to sites of degradation ( Figures  3B-3E ). Active sites of degradation were visible by loss of fluorescence of the gelatin ( Figure 3C ), and these sites corresponded with accumulations of vesicles of GFP-VAMP7 visualized by TIRF ( Figures 3B and 3D ), indicating that these vesicles are close to the ventral plasma membrane. Importantly, recruitment of GFP-VAMP7 vesicles to this site was observed ( Figure 3E , arrow, and Movie S2). Upon dynamic recruitment to this site, these vesicles seemed to dock at this place ( Figure 3E, asterisk) . These nearly immobile vesicles might represent primed vesicles that are ready to release their content [29] . Additionally, we observed tubulogenesis from large GFP-VAMP7-and MT1-MMP-mCherry-positive vesicular structures in the vicinity of the ventral plasma membrane (Movie S3), suggesting that transport intermediates were pinched off from LE/lysosomal compartments for trafficking of the protease to invadopodia. The high degree of colocalization of VAMP7 and MT1-MMP at sites of degradation suggests an important functional role for VAMP7 in targeted delivery of the protease underlying the mechanism of MT1-MMP accumulation at invadopodia.
Depletion of VAMP7 Impairs MT1-MMP-Dependent Degradation and Invasion
We investigated a specific role of VAMP7 for MT1-MMP-dependent ECM proteolysis. First, we analyzed the significance of MT1-MMP itself for matrix degradation in human cancer cells. MDA-MB-231 cells were efficiently knocked down with siRNAs specific to MT1-MMP ( Figure S2A ), and depletion of MT1-MMP completely abolished the capacity of these cells as well as MDA-MT1ch cells to degrade the matrix ( Figures  4G-4I 0 and 4J, and Figures S2D-S2D 00 ), confirming the paramount importance of MT1-MMP in cellular invasiveness [4, 8, 9] . To address the relevance of VAMP7 in MT1-MMP-dependent degradation, we analyzed matrix proteolysis of MDA-MB-231 and MDA-MT1ch cells depleted for VAMP7. VAMP7 knockdown with two independent siRNAs ( Figure S2A ) resulted in w60%-70% reduction in the degradative capacity of MDA-MB-231 cells as compared to mock-treated cells (Figures 4A-4F 0 and 4J and Figures S2B-S2C 00 ). Consistently, even in the background of stably overexpressed MT1-MMPmCherry, depletion of VAMP7 with two different siRNAs inhibited matrix degradation to similar extents ( Figure 4J ). VAMP7 depletion from MDA-MB-231 cells did neither affect total protein levels of MT1-MMP ( Figure S2E ) nor change the preferential association to LE/lysosomes (data not shown). This implies that VAMP7 is required for efficient matrix proteolysis exerted by endogenous as well as ectopically expressed MT1-MMP.
To investigate cancer cell invasion through a stiff extracellular matrix, we compared mock-treated MDA-MB-231 cells with VAMP7-depleted MDA-MB-231 cells in a Matrigel transwell assay as a model of basement-membrane invasion. VAMP7 depletion resulted in a 40% reduced capacity to pass the Matrigel lattice as compared with mock-treated cells ( Figure 4K ). Of note, under similar conditions, MT1-MMP depletion led to 60% inhibition of invasion through Matrigel [16] . Conversely, stable overexpression of MT1-MMP-mCherry (MDA-MT1ch cells) increased the invasion capacity to 140% as compared with mock-treated cells ( Figure 4K ), confirming previous results [6, 7, 9] . We then tested the effect of VAMP7 loss of function on 3D migration in collagen I matrix. Mock and VAMP7-depleted cells were embedded in collagen I and analyzed by time-lapse microscopy. As already reported [30] , mock-treated MDA-MB-231 cells displayed mainly a mesenchymal mode of migration (64% mesenchymal versus 36% amoeboid). On the contrary, VAMP7 depletion led to an inversion of phenotype (42% mesenchymal versus 58% amoeboid, see Figures S3A and S3B and Movie S4) and affected neither speed nor directional persistence of migration ( Figure S4 ). Altogether, our results are in agreement with recent data showing that invasion through 3D collagen matrix may be only partially dependent on pericellular proteolysis and that cells can switch from mesenchymal to amoeboid movement upon MMP inhibition [30, 31] . MT1-MMP-mediated pericellular proteolytic activity is required for cancer cells to breach the basal membrane and for mesenchymal migration in fibrillar collagen matrix [6, 9, 31] . Our observations that VAMP7 is important for both 3D mesenchymal migration in collagen I and invasion through reconstituted basement membrane as well as gelatin degradation strongly argue that VAMP7 is a pivotal regulator of MT1-MMP-mediated matrix degradation and invasion.
Invadopodia Formation Is Coupled to Its Proteolytic Machinery
Analysis of the structural components required for invadopodia formation revealed several components such as N-WASP, Arp2/3 complex, and cortactin, which constitute the actin polymerization machinery. Signaling molecules such as c-Src orchestrate the formation of invadopodia (for review, see [32] ). Interestingly, it has been proposed recently that MT1-MMP expression and activity are required for formation and maturation of invadopodia in SCC61 squamous cell carcinoma and MDA-MB-231 cell lines [3, 4] . Thus, we wondered whether impairment of MT1-MMP exocytosis by VAMP7 depletion affected formation of invadopodia. We analyzed invadopodia formation in MDA-MB-231 cells plated on fluorescently labeled matrix, stained for filamentous actin and cortactin [3, 4] . In mock-treated cells, we readily observed invadopodia in which F-actin and cortactin staining perfectly colocalized ( Figures 4A-4B 0 ). In some instances, the gelatin degradation was even broader ( Figures 4C and 4C 0 ), corresponding to previous sites of proteolytic degradation no longer associated with invadopodia as described [33] . Notably, the intensity and number of F-actin and cortactin doubly stained structures was decreased in VAMP7-depleted cells ( Figures 4D-4E 0 ), and these were associated with reduced proteolysis of the underlying matrix ( Figures 4F and 4F 0 ). In MT1-MMP-depleted cells, invadopodia were strongly reduced (Figures 4G-4H 0 ), and matrix proteolysis was abolished ( Figures 4I  and 4I 0 ; see also Figures S2B-S2D 00 ). Quantification of invadopodia resulted in 19% of mock-treated cells displaying invadopodia, whereas this number was reduced to 8%-9% in VAMP7-depleted cells and less than 5% of MT1-MMPsiRNA-treated cells ( Figure 4L ). The number of invadopodia per cell was greatly reduced in VAMP7 cells, although not as strongly affected as in MT1-MMP-siRNA-treated cells (Figure 4L) . Strikingly, VAMP7-depleted cells showed reduced amount of surface MT1-MMP clusters at the extracellular site of invadopodia, although total MT1-MMP levels were not Differences between all siRNA-treated populations and respective mock populations from all quantifications were confirmed to be statistically significant (see Table S1 ). The number of experiments (N) and total number of cells (n) are indicated.
affected (see Figures 4M-4P
0 and Figure S2E ; 18% of mocktreated cells showed MT1-MMP accumulations at the ventral plasma membrane versus 5%-8% in VAMP7-siRNA-treated cells, Figure 4Q ). Altogether, the data presented here strongly argue for VAMP7 being a critical SNARE during directed delivery of MT1-MMP to invadopodia. Furthermore, our findings that prevention of MT1-MMP delivery (VAMP7 siRNA) or expression (MT1-MMP siRNA) led to reduced invadopodia number agree with recent reports suggesting that MT1-MMP contributes to invadopodia formation and/or maturation [3, 4] ; i.e., invadopodia formation in VAMP7-depleted cells is blocked or arrested in a premature state, at which accumulation of the protease is blocked.
The paramount importance of MT1-MMP for cancer cell invasion is well documented [7] [8] [9] . We addressed here the question of how the protease is localized to sites of matrix proteolysis and connect for the first time a v-SNARE to its cargo MT1-MMP. VAMP7 and MT1-MMP are colocalized at proteolytic sites; furthermore, depletion of VAMP7 phenocopied partially the effect of MT1-MMP depletion from cancer cells, leading to reduced degradative and invasive capacities. Strikingly, silencing of VAMP7 resulted in a reduced invadopodia number, which was accompanied by significantly lesser amounts of MT1-MMP accumulated at the ventral side of the cells facing the ECM. Finally, loss of VAMP7 resulted in a switch from mesenchymal to amoeboid mode of migration. Altogether, these data identify VAMP7 as a key cellular factor necessary for MT1-MMP-dependent matrix degradation, suggesting LE/lysosomal exocytosis to be an important process for matrix degradation by tumor cells. Beyond its relevance for signaling leading to known consequences for actin polymerization at invadopodia, our study pinpoints membrane trafficking as an essential component of the mechanisms of invadopodia formation and activity.
Supplemental Data
Experimental Procedures, four figures, one table, and four movies are available at http://www.current-biology.com/cgi/content/full/18/12/926/DC1/.
